Mouse Embryonic Stem Cells
mESCs expressing a fluorescently tagged transcription factor under doxycycline control
By: amalabgenetics
Go here to read the rest:
Mouse Embryonic Stem Cells - Video
Stem Cells: Revolutionizing the World
My First Project
By: TheBLDTV
See the original post:
Stem Cells: Revolutionizing the World - Video
Moiz Mohammed - Immunosuppressive Effects of Mesenchymal Stem Cells in Neonates
Rutgers #39; Molecular Biology undergraduate, Moiz Mohammed discusses his research on Bronchopulmonary Dysplasia, a lung disease found in premature babies.
By: Rutgers
Read more:
Moiz Mohammed - Immunosuppressive Effects of Mesenchymal Stem Cells in Neonates - Video
Social Studies Final Project Stem Cells
By: ZachH197
See the rest here:
Social Studies Final Project Stem Cells - Video
MANILA, Philippines --- The Department of Health (DOH) is preparing guidelines for the use of stem cell therapy in the treatment of diseases in the Philippines.
This was announced by DOH Secretary Enrique T. Ona yesterday in a convention on stem cell therapy at the Manila Hotel.
Ona said a bio-ethics advisory board will develop the guidelines which will include ethical standards in the application of stem cell therapy to treat diseases such as malignancies, blood disorders and metabolic disorders, among others.
"The institutional board will review and approve Stem Cell therapies based on guidelines by the advisory board," Ona said.
He added that the board will also include ethical and legal issues surrounding stem cell therapy.
Last week, the Philippine Medical Association (PMA) and the Philippine Society for Stem Cell Medicine (PSSCM) issued a joint statement that warned against the dangers of receiving stem cell transplants that came from another source other than the patient's body.
"If the stem cell that you received is not from your own body, it could lead to fatal complications," Philippine Society for Stem Cell Medicine (PSSCM) and the PMA said.
The doctors warned that complications arising from stem cell transplants include graft-versus-host disease, stem cell (graft) failure, organ injury, infections, cataracts, infertility, new cancers, and even death.
Ona said a public hearing will be held on January 18 regarding the preliminary draft of the guidelines.
He said the guidelines will ensure the minimum quality of service and application in the use of stem cells in health settings.
The rest is here:
Stem Cell Therapy Guidelines Readied
#32 - Tissue Repair - Stem cells, the cell cycle overview, (G1, S, G2, mitosis phases)
To understand physiologic cell proliferation (as in repair) and pathologic proliferation (as in cancer), it is important to learn about the cell cycle and its regulation.
By: Kevin Mangum
Read more:
#32 - Tissue Repair - Stem cells, the cell cycle overview, (G1, S, G2, mitosis phases) - Video
Producing Stem Cells In Your Own Body
Exercise helps keep your body and brain healthy by producing stem cells.
By: Andy Vantreese
See the rest here:
Producing Stem Cells In Your Own Body - Video
#33 - Tissue regeneration, stem cells, regenerative medicine
The ability of tissues to repair themselves is influenced by their capacity to regenerate the missing tissue and their ability that is inherent for them to divide and undergo mitosis. In most continuously dividing tissues the mature cells are terminally differentiated and short-lived. As mature cells die the tissue is replenished by the differentiation of cells generated from stem cells. Thus, in these tissues there is a homeostatic equilibrium between the replication and differentiation of stem cells and the death of the mature, fully differentiated cells. Regenerative medicine is the "process of replacing or regenerating human cells, tissues or organs to restore or establish normal function".
By: Kevin Mangum
View post:
#33 - Tissue regeneration, stem cells, regenerative medicine - Video
MOUNTAIN VIEW, Calif., Jan. 14, 2013 /PRNewswire/ --SanBio Inc. today announced the successful enrollment of the second dose cohort of patients in its Phase 1/2a clinical trial testing the safety and efficacy of a novel allogeneic stem cell therapy product, SB623, in patients suffering from chronic deficits resulting from previous stroke injuries. The first 12 patients, of a planned total of 18, have been successfully administered SB623. The trial is being conducted at Stanford University, the University of Pittsburgh and Northwestern University. No safety concerns have been attributed to the cell therapy product. For details regarding this clinical trial, please refer to http://www.strokeclinicaltrial.org.
SB623 is derived from adult bone marrow and has shown safety and efficacy in rodent models of chronic stroke. "The successful completion of the first two dose cohorts of this pioneering clinical trial is a clear indication of the dedication and professionalism of the entire team," said Keita Mori, SanBio CEO.
SB623 is being delivered to the damaged region of the brains of patients who have suffered an ischemic stroke. Product safety is the primary focus of the study but various measurements of efficacy are also being tested.
"We are pleased with the safety findings of the study thus far," said Dr. Ernest Yankee, SanBio's Executive Vice President of Development. "We anticipate completing the enrollment of the third and final dose cohort early in the year and reporting the results shortly thereafter."
About SB623: SB623 is a proprietary cell therapy product consisting of cells derived from genetically engineered bone marrow stromal cells obtained from healthy adult donors. SB623 is administered adjacent to the area damaged by stroke and functions by producing proteins that aid the regenerative process.
About SanBio: SanBio is a privately held San Francisco Bay Area biotechnology company focused on the discovery and development of new regenerative cell therapy products.
For more information: http://www.san-bio.com
See the original post here:
SanBio Announces Enrollment Of The Second Cohort Of Patients In Its Clinical Trial Of Stem Cell Therapy For Chronic ...
Why are stem cells important .mp4
http://www.stemcellsarthritistreatment.com Stem cells are important for for many reasons. In the 3- to 5-day-old embryo, cells give rise to the entire body of the organism, including all of the many specialized cell types and organs. In some adult tissues, such as bone marrow, muscle, and brain, discrete populations of adult stem cells generate replacements for cells that are lost through normal wear and tear, injury, or disease. Given their unique regenerative abilities, stem cells offer new potentials for treating diseases. http
By: Nathan Wei
More here:
Why are stem cells important .mp4 - Video
Stem cells improve function in mouse model of Lou Gehrig #39;s disease
From Italy -- A new report presented at the annual meeting for the American Academy of Neurology finds that stem cells may have potential in treating amyotrophic lateral sclerosis (ALS). Researchers studied an animal model of ALS (also known as Lou Gehrig #39;s disease), injecting the rodents with neural stem cells taken from a human. Results showed that the stem cells migrated to the spinal cord and successfully multiplied. As a result, the mice had a significantly extended lifespan and a 15% improvement in their neuromuscular function.
By: insidermedicine
More:
Stem cells improve function in mouse model of Lou Gehrig's disease - Video
Dr. Rob Dickerman uses patient #39;s own stem cells to heal back pain
Video from Channel 8 news in Dallas.
By: actional86
Originally posted here:
Dr. Rob Dickerman uses patient's own stem cells to heal back pain - Video
Progress with Neural Stem Cells - Drs. Hans Keirstead Paul Lu, Advocate Roman Reed
Video of the Question Answer Session following presentations by Drs. Hans Keirstead and Mark Tuszynski.
By: unite2fightparalysis
See the rest here:
Progress with Neural Stem Cells - Drs. Hans Keirstead
The Powers of Dental Pulp Derived Stem Cells DPSC Overview and Technology
Dental pulp derived stem cells can be used to repair teeth, by facilitating the growth of dentin or pul pulp in a compromised tooth. thaimedicalvacation.com It also allows for the creation of biological scaffolding from wisdom teeth. The re-growth of dental pulp and dentin was don to apply the successful methods to repair damage caused by dental trauma. Dental Pulp stem cells have the ability to differentiate into various other types of tissue such as bone, neural cells and as a source for iPS derived cells, Dental stem cells Can also be a potential source of stem cells that can be utilized to treat a wide variety of disease and trauma as regenerative medical treatments.
By: stemcellthailand
See the article here:
The Powers of Dental Pulp Derived Stem Cells DPSC Overview and Technology - Video
Beating Cardiomyocytes from human embryonic stem cells.avi
Human embryonic stem cells were differentiated into beating cardiomyocytes via embryoid body mediated differentiation. STEM CELL LIFE SCIENCE CONSULTING
By: SCLSConsulting
The rest is here:
Beating Cardiomyocytes from human embryonic stem cells.avi - Video
The Science Of The Next 150 Years: 50 Years in the Future [More]
http://rss.sciam.com/click.phdo?i=72f945621480bfc5969f6a7a29254aaf
What scientific and technological milestones can we envision 50, 100 and 150 years hence?
http://rss.sciam.com/click.phdo?i=bb22bbe61dfa476fb230c7787f0d7954
Roman Reed, a Fremont, Ca., patient advocate, this week was named Stem
Cell Person of 2012 by the Knoepfler Stem Cell Lab at UC Davis, which
cited Reed for energizing a new generation of
advocacy.
 |
| Roman Reed (left) and Paul Knoepfler Knoepfler Lab photo |
“One of the most notable was
catalyzing the TJ Atchison Spinal Cord Injury Research Act in
Alabama, which provides $400,000/year in funding for research. Of
course, TJ and many others who helped make this possible also deserve
great credit and have my admiration, but Roman provided key
leadership. Here in California, Roman’s Law supported its 11th
year of grants all eligible for all forms of stem cell research.
Roman informs me that it funded $749,00 overall and approximately
$200,000 in stem cell funding.
“In addition, Roman in 2012 mentored
and energized a whole new generation of advocacy from young,
energetic leaders: TJ Atchison, Katie Sharify, Richard Lajara
and Tory Minus.”
 |
| Leigh Turner U of Minn photo |
“Only 6% behind Roman was the amazing
activist Ted Harada followed by Roman’s dad the remarkable Don
Reed, the wonderful Judy Roberson, and the super Katie Sharify nearly
all tied for third. Next after them was the relative new kid in stem
cell town, Leigh Turner.”
“Leigh took the courageous,
outside-the-box step in 2012 of contacting the FDA to investigate
Celltex when he perceived patients could be at risk. As “thanks”
for his action, he was put under enormous pressure and there was talk
of possible litigation against him. Pressure was applied to his
employer, the University of Minnesota. We’ll never know for sure,
but from everything that I know I believe that Leigh’s actions
directly led to prompt FDA action, which otherwise might not have
happened at all or until much later. In my opinion, Leigh’s act of
courage, helped make hundreds of patients safer in a direct way and
indirectly may have set a higher standard for the field of stem cell
treatments.”
The stock price of Biotime, Inc., of
Alameda, Ca., shot up more than 12 percent today following the
announcement of a complex deal that will give it the stem cell assets
of Geron Corp., the first firm to launch a clinical trial for an hESC
therapy.
 |
| Geron stock price Jan. 2-8 Google chart |
Source:
Source:
Source: